STUDENTS of late-20th-century politics and history might recall that the term ‘Lost Decade’ is used to describe the 1980s in ...

Reckitt Benckiser Group plc (RBGLY) earns a hold rating due to its strong emerging markets exposure and ongoing portfolio ...

ArriVent BioPharma's furmonertinib demonstrates robust efficacy, CNS penetration, and tolerability in early trials. Read why ...

Dr Eliane Bodanese, an engineering lecturer at Queen Mary University, was twice rejected for a promotion which was instead ...

A recent randomised controlled trial showed that proton pump inhibitors (PPIs), compared with histamine-2 receptor antagonists (H2RAs), induce greater gut microbiome alterations and oral-to-gut ...

Precision CNC machining enhances India's manufacturing quality and efficiency. Learn how advanced CNC processes improve ...

Organisation of African, Caribbean and Pacific States (OACPS), German Federal Ministry for Economic Cooperation and Development (BMZ), Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ), ...

Nature Medicine asked leading researchers to name their top clinical trial for 2026, from long-awaited vaccines for infectious diseases to new ...

Some say the post-war liberal order died in 2025. But while US President Donald Trump may have accelerated its demise, it was ...

Takeda (TSE:4502/NYSE:TAK) today announced positive topline results for the two pivotal Phase 3 randomized, multicenter, double-blind, placebo- and active comparator-controlled studies of zasocitinib ...

Strong adherence and safety. Long-term cost savings depend heavily on patient adherence. While twice-daily dosing may pose some risk, its safety profile and novel mechanism—targeting NMDA and sigma-1 ...

ExxonMobil is working on a number of solutions to help advance lower-emission fuels within the commercial transportation sector.